{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:57Z","timestamp":1787019537935,"version":"build-2736575974"},"reference-count":56,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,30]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Multiple myeloma cells inhibit myeloma-specific T cells through expression of carcinoembryonic antigen-related cell adhesion molecule-6.<\/jats:p>","DOI":"10.1182\/blood-2012-05-429415","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T23:21:10Z","timestamp":1366413670000},"page":"4493-4503","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":46,"title":["Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6"],"prefix":"10.1182","volume":"121","author":[{"given":"Mathias","family":"Witzens-Harig","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"},{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"J\u00fcnger","sequence":"additional","affiliation":[{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"},{"name":"Translational Immunology Division, German Cancer Research Center, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pfirschke","sequence":"additional","affiliation":[{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"},{"name":"Translational Immunology Division, German Cancer Research Center, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisit","family":"Khandelwal","sequence":"additional","affiliation":[{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"},{"name":"Translational Immunology Division, German Cancer Research Center, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Umansky","sequence":"additional","affiliation":[{"name":"Translational Immunology Division, German Cancer Research Center, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinke","family":"Conrad","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Klinikum rechts der Isar, Technische Universit\u00e4t, M\u00fcnchen, Munich, Germany;"},{"name":"Division of Immunogenetics, German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Brackertz","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Klinikum rechts der Isar, Technische Universit\u00e4t, M\u00fcnchen, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"R\u00e8me","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale 1040, U1040, Montpellier, France;"},{"name":"Centre Hospitalier Universitaire Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Universit\u00e9 Montpellier 1, Unit\u00e9 de Formation et de Recherche M\u00e9decine, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gueckel","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital of T\u00fcbingen, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Mei\u00dfner","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Rossi","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale 1040, U1040, Montpellier, France;"},{"name":"Universit\u00e9 Montpellier 1, Unit\u00e9 de Formation et de Recherche M\u00e9decine, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Neben","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Bernhard","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Klinikum rechts der Isar, Technische Universit\u00e4t, M\u00fcnchen, Munich, Germany;"},{"name":"Department of Hematology\/Oncology, Klinikum Darmstadt Gesellschaft mit beschr\u00e4nkter Haftung, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Hospital of Heidelberg, Heidelberg, Germany;"},{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale 1040, U1040, Montpellier, France;"},{"name":"Centre Hospitalier Universitaire Montpellier, Institute of Research in Biotherapy, Montpellier, France;"},{"name":"Universit\u00e9 Montpellier 1, Unit\u00e9 de Formation et de Recherche M\u00e9decine, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Beckhove","sequence":"additional","affiliation":[{"name":"Nationales Centrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany;"},{"name":"Translational Immunology Division, German Cancer Research Center, Deutsches Krebsforschungszentrum, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111816083950200_B1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI200420278","article-title":"Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.","volume":"114","author":"Beckhove","year":"2004","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111816083950200_B2","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2004-01-0366","article-title":"Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.","volume":"105","author":"Choi","year":"2005","journal-title":"Blood"},{"issue":"16","key":"2019111816083950200_B3","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1158\/0008-5472.CAN-05-4201","article-title":"The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients.","volume":"66","author":"Sommerfeldt","year":"2006","journal-title":"Cancer Res"},{"issue":"21","key":"2019111816083950200_B4","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1158\/0008-5472.CAN-05-1098","article-title":"High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.","volume":"65","author":"Schmitz-Winnenthal","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"2019111816083950200_B5","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","article-title":"Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.","volume":"97","author":"J\u00e4ger","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111816083950200_B6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(06)92005-7","article-title":"The human T cell response to melanoma antigens.","volume":"92","author":"Romero","year":"2006","journal-title":"Adv Immunol"},{"issue":"4","key":"2019111816083950200_B7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/86523","article-title":"Therapy of human tumors in NOD\/SCID mice with patient-derived reactivated memory T cells from bone marrow.","volume":"7","author":"Feuerer","year":"2001","journal-title":"Nat Med"},{"issue":"17","key":"2019111816083950200_B8","first-page":"5582","article-title":"Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cells.","volume":"63","author":"Letsch","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"2019111816083950200_B9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/156800907780006940","article-title":"Cellular and molecular mechanisms of tumor-induced T-cell tolerance.","volume":"7","author":"Horna","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"2019111816083950200_B10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0065-230X(04)92002-7","article-title":"Tumor-host immune interactions and dendritic cell dysfunction.","volume":"92","author":"Yang","year":"2004","journal-title":"Adv Cancer Res"},{"issue":"6","key":"2019111816083950200_B11","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma.","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"issue":"9023","key":"2019111816083950200_B12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(05)64525-4","article-title":"Graft-versus-myeloma effect.","volume":"348","author":"Aschan","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"2019111816083950200_B13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","article-title":"Graft-versus-myeloma effect: proof of principle.","volume":"87","author":"Tricot","year":"1996","journal-title":"Blood"},{"issue":"9","key":"2019111816083950200_B14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bmt.1703253","article-title":"Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect.","volume":"28","author":"Le Blanc","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"22","key":"2019111816083950200_B15","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2010.32.7312","article-title":"Tandem autologous\/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.","volume":"29","author":"Bj\u00f6rkstrand","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111816083950200_B16","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","article-title":"Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.","volume":"88","author":"Bj\u00f6rkstrand","year":"1996","journal-title":"Blood"},{"issue":"1","key":"2019111816083950200_B17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0889-8588(05)70420-2","article-title":"Allogeneic stem cell transplantation for multiple myeloma.","volume":"11","author":"Bensinger","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2019111816083950200_B18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","article-title":"Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.","volume":"113","author":"Gahrton","year":"2001","journal-title":"Br J Haematol"},{"issue":"6 Suppl 17","key":"2019111816083950200_B19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/sonc.2002.34074","article-title":"High-dose therapy and immunomodulatory drugs in multiple myeloma.","volume":"29","author":"Barlogie","year":"2002","journal-title":"Semin Oncol"},{"issue":"12","key":"2019111816083950200_B20","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20021650","article-title":"A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"2019111816083950200_B21","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood.V87.8.3297.bloodjournal8783297","article-title":"Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia.","volume":"87","author":"Moss","year":"1996","journal-title":"Blood"},{"issue":"8","key":"2019111816083950200_B22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.leu.2400714","article-title":"The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma.","volume":"11","author":"Brown","year":"1997","journal-title":"Leukemia"},{"issue":"6","key":"2019111816083950200_B23","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood.V97.6.1750","article-title":"Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.","volume":"97","author":"Wen","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2019111816083950200_B24","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2002-04-1250","article-title":"T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma.","volume":"101","author":"Hansson","year":"2003","journal-title":"Blood"},{"issue":"20","key":"2019111816083950200_B25","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.1073\/pnas.202491499","article-title":"T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.","volume":"99","author":"Dhodapkar","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111816083950200_B26","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20031030","article-title":"Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.","volume":"198","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"2019111816083950200_B27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2249.2001.01582.x","article-title":"Deregulated cytokine network and defective Th1 immune response in multiple myeloma.","volume":"125","author":"Frassanito","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"2019111816083950200_B28","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2002.05.033","article-title":"CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.","volume":"20","author":"Thies","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111816083950200_B29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1532\/IJH97.06169","article-title":"Carcinoembryonic antigen-producing multiple myeloma detected by a transcription-reverse transcription concerted reaction system.","volume":"85","author":"Kaito","year":"2007","journal-title":"Int J Hematol"},{"issue":"5","key":"2019111816083950200_B30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcla.1860050510","article-title":"Carcinoembryonic antigen gene family: molecular biology and clinical perspectives.","volume":"5","author":"Thompson","year":"1991","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"2019111816083950200_B31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: their role in physiology and pathophysiology.","volume":"18","author":"Kuespert","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"2019111816083950200_B32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nri1864","article-title":"CEACAM1: contact-dependent control of immunity.","volume":"6","author":"Gray-Owen","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111816083950200_B33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","article-title":"Cell adhesion and signalling by cadherins and Ig-CAMs in cancer.","volume":"4","author":"Cavallaro","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2019111816083950200_B34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","article-title":"Clinical and prognostic role of annexin A2 in multiple myeloma.","volume":"120","author":"Seckinger","year":"2012","journal-title":"Blood"},{"issue":"18","key":"2019111816083950200_B35","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","article-title":"Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.","volume":"113","author":"Hose","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111816083950200_B36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood-2008-10-184226","article-title":"Induction of angiogenesis by normal and malignant plasma cells.","volume":"114","author":"Hose","year":"2009","journal-title":"Blood"},{"issue":"44","key":"2019111816083950200_B37","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2009.257","article-title":"Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.","volume":"28","author":"Seckinger","year":"2009","journal-title":"Oncogene"},{"issue":"23","key":"2019111816083950200_B38","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1158\/1078-0432.CCR-11-1628","article-title":"Gene expression profiling in multiple myeloma\u2014reporting of entities, risk, and targets in clinical routine.","volume":"17","author":"Meissner","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"21","key":"2019111816083950200_B39","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1158\/0008-5472.CAN-09-1627","article-title":"Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis.","volume":"69","author":"Domschke","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2019111816083950200_B40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00262-004-0583-z","article-title":"A CD80-transfected human breast cancer cell variant induces HER-2\/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo.","volume":"54","author":"G\u00fcckel","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"25","key":"2019111816083950200_B41","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2009-11-254078","article-title":"Coexpression of the T-cell receptor constant alpha domain triggers tumor reactivity of single-chain TCR-transduced human T cells.","volume":"115","author":"Voss","year":"2010","journal-title":"Blood"},{"issue":"15","key":"2019111816083950200_B42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djm064","article-title":"Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.","volume":"99","author":"Nummer","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2019111816083950200_B43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.10781","article-title":"Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.","volume":"103","author":"Bai","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"2019111816083950200_B44","first-page":"174","article-title":"Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.","volume":"9","author":"Solomayer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2019111816083950200_B45","first-page":"290536","article-title":"Serum CEACAM1 correlates with disease progression and survival in malignant melanoma patients.","volume-title":"Clin Dev Immunol","author":"Sivan","year":"2012"},{"issue":"10","key":"2019111816083950200_B46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2011.03.013","article-title":"High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis.","volume":"35","author":"Hasselbalch","year":"2011","journal-title":"Leuk Res"},{"issue":"2","key":"2019111816083950200_B47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1078-0432.CCR-07-1363","article-title":"Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.","volume":"14","author":"Maraqa","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2019111816083950200_B48","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1182\/blood-2009-10-246991","article-title":"Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy.","volume":"115","author":"Li","year":"2010","journal-title":"Blood"},{"issue":"Suppl 2","key":"2019111816083950200_B49","doi-asserted-by":"crossref","first-page":"B72","DOI":"10.1016\/j.vaccine.2007.06.043","article-title":"Enhancing cancer vaccines with immunomodulators.","volume":"25","author":"Berinstein","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"2019111816083950200_B50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy.","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2019111816083950200_B51","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.180.10.6827","article-title":"CEACAM1 dynamics during neisseria gonorrhoeae suppression of CD4+ T lymphocyte activation.","volume":"180","author":"Lee","year":"2008","journal-title":"J Immunol"},{"issue":"Pt 2","key":"2019111816083950200_B52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1242\/jcs.114.2.243","article-title":"T cell receptor signalling.","volume":"114","author":"Lin","year":"2001","journal-title":"J Cell Sci"},{"issue":"8","key":"2019111816083950200_B53","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/MCB.17.8.4434","article-title":"Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase.","volume":"17","author":"Latour","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019111816083950200_B54","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function.","volume":"185","author":"Wen","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"2019111816083950200_B55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00277-007-0388-1","article-title":"High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.","volume":"87","author":"Lasa","year":"2008","journal-title":"Ann Hematol"},{"issue":"19","key":"2019111816083950200_B56","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2003.55.135","article-title":"Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.","volume":"21","author":"Jantscheff","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4493\/1365904\/4493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/22\/4493\/1365904\/4493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T08:00:52Z","timestamp":1644825652000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/22\/4493\/31362\/Tumor-cells-in-multiple-myeloma-patients-inhibit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":56,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2013,5,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-429415","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}